+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Implantable Cardioverter Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
Implantable Cardioverter Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
New

Implantable Cardioverter Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • PDF Icon

    Report

  • 184 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5941850
Free Webex Call
10% Free customization
Description Jump to:

T-ICDs is the fastest growing segment, North America is the largest market globally

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Implantable Cardioverter Defibrillator Market, valued at USD 3.62 Billion in 2024, is projected to experience a CAGR of 6.53% to reach USD 5.29 Billion by 2030. An Implantable Cardioverter Defibrillator (ICD) is a medical device surgically placed to continuously monitor cardiac rhythm and deliver electrical therapy, such as defibrillation or pacing, to correct life-threatening arrhythmias and prevent sudden cardiac arrest. The global market's expansion is driven by the increasing prevalence of cardiovascular diseases, an aging population more susceptible to cardiac conditions, and technological advancements enhancing device efficiency and longevity.

Key Market Drivers

The increasing incidence of cardiovascular diseases and sudden cardiac arrest serves as a primary driver for the global implantable cardioverter defibrillator market. As populations age and lifestyles introduce new cardiac risk factors, the number of individuals susceptible to life-threatening arrhythmias requiring ICD therapy expands. These critical cardiac events necessitate effective interventions to prevent sudden cardiac death and improve patient outcomes.

Key Market Challenges

A primary challenging factor confronting the global implantable cardioverter defibrillator market is the considerable expenditure associated with both device implantation and subsequent long-term patient care. These substantial financial hurdles directly restrict patient access to necessary therapy, particularly within regions characterized by developing healthcare infrastructures. This limitation on accessibility translates into a slower adoption rate for implantable cardioverter defibrillators, thereby impeding the overall market expansion.

Key Market Trends

Artificial intelligence and machine learning are significantly impacting the Global Implantable Cardioverter Defibrillator Market by enhancing diagnostic precision and optimizing therapy. These technologies empower ICDs to analyze vast cardiac data for personalized treatment. The 2025 Scientific Statement from the European Heart Rhythm Association, Heart Rhythm Society, and ESC Working Group on E-Cardiology highlighted AI's potential in advanced arrhythmia detection and outcome prediction.

Key Market Players Profiled:

  • Abbott Laboratories Inc.
  • Medtronic Plc
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • LivaNova PLC

Report Scope:

In this report, the Global Implantable Cardioverter Defibrillator Market has been segmented into the following categories:

By Product:

  • Transvenous Implantable Cardioverter Defibrillators
  • Subcutaneous Implantable Cardioverter Defibrillators

By Type:

  • Single Chamber ICDs
  • Dual Chamber ICDs
  • Biventricular Devices

By NYHA Class:

  • NYHA Class II
  • NYHA Class III

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Implantable Cardioverter Defibrillator Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:
  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Implantable Cardioverter Defibrillator Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators)
5.2.2. By Type (Single Chamber ICDs, Dual Chamber ICDs, Biventricular Devices)
5.2.3. By NYHA Class (NYHA Class II, NYHA Class III)
5.2.4. By End-User (Hospitals, Ambulatory Surgical Centers, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Implantable Cardioverter Defibrillator Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Type
6.2.3. By NYHA Class
6.2.4. By End-User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Implantable Cardioverter Defibrillator Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Type
6.3.1.2.3. By NYHA Class
6.3.1.2.4. By End-User
6.3.2. Canada Implantable Cardioverter Defibrillator Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Type
6.3.2.2.3. By NYHA Class
6.3.2.2.4. By End-User
6.3.3. Mexico Implantable Cardioverter Defibrillator Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Type
6.3.3.2.3. By NYHA Class
6.3.3.2.4. By End-User
7. Europe Implantable Cardioverter Defibrillator Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By NYHA Class
7.2.4. By End-User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Implantable Cardioverter Defibrillator Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Type
7.3.1.2.3. By NYHA Class
7.3.1.2.4. By End-User
7.3.2. France Implantable Cardioverter Defibrillator Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Type
7.3.2.2.3. By NYHA Class
7.3.2.2.4. By End-User
7.3.3. United Kingdom Implantable Cardioverter Defibrillator Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Type
7.3.3.2.3. By NYHA Class
7.3.3.2.4. By End-User
7.3.4. Italy Implantable Cardioverter Defibrillator Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Type
7.3.4.2.3. By NYHA Class
7.3.4.2.4. By End-User
7.3.5. Spain Implantable Cardioverter Defibrillator Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Type
7.3.5.2.3. By NYHA Class
7.3.5.2.4. By End-User
8. Asia Pacific Implantable Cardioverter Defibrillator Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By NYHA Class
8.2.4. By End-User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Implantable Cardioverter Defibrillator Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Type
8.3.1.2.3. By NYHA Class
8.3.1.2.4. By End-User
8.3.2. India Implantable Cardioverter Defibrillator Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Type
8.3.2.2.3. By NYHA Class
8.3.2.2.4. By End-User
8.3.3. Japan Implantable Cardioverter Defibrillator Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Type
8.3.3.2.3. By NYHA Class
8.3.3.2.4. By End-User
8.3.4. South Korea Implantable Cardioverter Defibrillator Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Type
8.3.4.2.3. By NYHA Class
8.3.4.2.4. By End-User
8.3.5. Australia Implantable Cardioverter Defibrillator Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Type
8.3.5.2.3. By NYHA Class
8.3.5.2.4. By End-User
9. Middle East & Africa Implantable Cardioverter Defibrillator Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Type
9.2.3. By NYHA Class
9.2.4. By End-User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Implantable Cardioverter Defibrillator Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Type
9.3.1.2.3. By NYHA Class
9.3.1.2.4. By End-User
9.3.2. UAE Implantable Cardioverter Defibrillator Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Type
9.3.2.2.3. By NYHA Class
9.3.2.2.4. By End-User
9.3.3. South Africa Implantable Cardioverter Defibrillator Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Type
9.3.3.2.3. By NYHA Class
9.3.3.2.4. By End-User
10. South America Implantable Cardioverter Defibrillator Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Type
10.2.3. By NYHA Class
10.2.4. By End-User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Implantable Cardioverter Defibrillator Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Type
10.3.1.2.3. By NYHA Class
10.3.1.2.4. By End-User
10.3.2. Colombia Implantable Cardioverter Defibrillator Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Type
10.3.2.2.3. By NYHA Class
10.3.2.2.4. By End-User
10.3.3. Argentina Implantable Cardioverter Defibrillator Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Type
10.3.3.2.3. By NYHA Class
10.3.3.2.4. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Implantable Cardioverter Defibrillator Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Abbott Laboratories Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Medtronic Plc
15.3. Biotronik SE & Co. KG
15.4. Boston Scientific Corporation
15.5. MicroPort Scientific Corporation
15.6. LivaNova PLC
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Abbott Laboratories Inc.
  • Medtronic Plc
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • LivaNova PLC

Table Information

Report AttributeDetails
No. of Pages184
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.29 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Implantable Cardioverter Defibrillators (ICDs) Market Report 2025 - Product Image

Implantable Cardioverter Defibrillators (ICDs) Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Implantable Cardioverter Defibrillator (ICD) Market - Forecasts from 2025 to 2030 - Product Image

Implantable Cardioverter Defibrillator (ICD) Market - Forecasts from 2025 to 2030

  • Report
  • 139 Pages
  • Global
From
Implantable Cardioverter Defibrillators (ICD) - Global Strategic Business Report - Product Image

Implantable Cardioverter Defibrillators (ICD) - Global Strategic Business Report

  • Report
  • 416 Pages
  • Global
From
Ventricular Tachycardia Devices Market Report and Forecast 2025-2034 - Product Image

Ventricular Tachycardia Devices Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Implantable Cardiac Devices Market Report 2025 - Product Image

Implantable Cardiac Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.